Neurosynthetics: Adaptive Dynamic Risk Factor Integration Network Architecture for Cardiac Risk Prediction

Cardiovascular diseases (CVDs) remain the leading cause of mortality globally, necessitating advancements in predictive analytics to preemptively identify individuals at elevated risk. The proposed neurosynthetics introduces a groundbreaking neural network framework designed to enhance cardiac risk stratification through dynamic feature synthesis and adaptive architecture optimization. The proposed model leverages raw clinical data, transforming it into a synthesized feature space using an embedded neural layer that captures complex interactions between physiological and demographic variables. The architecture employs a novel adaptive learning mechanism (ALM), which iteratively refines the neural structure in response to real-time validation metrics, fostering a balance between model complexity and predictive accuracy. In a retrospective cohort study utilizing patient data (n = 10,000), neurosynthetics demonstrated a predictive accuracy of 99.54%, outperforming conventional risk calculators, which was evidenced by the model's superior area under the receiver operating characteristic curve of 0.9982, compared to 0.83 achieved by traditional methods. Furthermore, the model's precision in identifying high-risk patients was underscored by a 15% improvement in positive predictive value. The ALM component was pivotal in enhancing performance, reducing overfitting, as indicated by a 5% increase in cross-validated accuracy. Neurosynthetics promises to revolutionize CVD risk assessment, enabling clinicians to predict 10-year cardiac risk with greater precision. With its capacity to adapt and evolve with incoming data positions, it is a powerful tool in the pursuit of personalized healthcare and proactive disease management strategies.